Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Home

Resources

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 10/07/19 by Anita Soma

Prescription pathway review for clinical trials in the chemotherapy unit

Abstracts

View resources
Last reviewed: 10/07/19 by Katherine Bayliss

Pilot study: Response rates and incidence of neutropenia in metastatic colorectal patients receiving Lonsurf® (trifluridine-tipiracil)

Abstracts

View resources
Last reviewed: 10/07/19 by Dr. Shereen Nabhani-Gebara

Perceptions of Oncology Pharmacists about their Visibility to Patients

Abstracts

View resources
Last reviewed: 10/07/19 by Kavita Kantilal

Patient satisfaction survey of an oncology pharmacy service to a myeloma outpatient clinic

Abstracts

View resources
Last reviewed: 10/07/19 by Andrea Preston

Overweight lymphoma patients treated by actual body weight had no excess of chemotherapy toxicity: Experience from two large trials

Abstracts

View resources
Last reviewed: 10/07/19 by Calum Polwart

Optimising the introduction of new cancer medicines across multiple National Health Service (NHS) hospitals within a single prescribing network

Abstracts

View resources
Last reviewed: 09/02/23 by Sophie Harding

Opinions of medical prescribers (NMP) and senior managers concerning non-medical prescribing practice in oncology

Abstracts

View resources
Last reviewed: 10/07/19 by Nisha Shaunak

Operational review of oncology pharmacy service at Guy’s & St Thomas’ Foundation Trust (GSTFT)

Abstracts

View resources
Last reviewed: 10/07/19 by Steve Williamson

Novel approach in DPD toxicity prevention to Improve Patient Safety

Abstracts

View resources
Last reviewed: 09/02/23 by Sophie Harding

Non-medical prescribers (NMP) opinions and beliefs concerning non-medical prescribing current practice within oncology

Abstracts

View resources
Last reviewed: 10/07/19 by Aishling McLoughlin

Ninety minute daratumumab infusion with a reduction in premedication is safe in multiple myeloma

Abstracts

View resources
Last reviewed: 10/07/19 by Dr. Hector Mateo-Carrasco

New oral therapies in breast cancer: an efficacy comparison using Bayesian network meta-analysis

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 103 104 105 … 109 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Conference 2024
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2025 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.